Heart Disease Clinical Trials in Baltimore, MD

178 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)	Phase 3	Novartis Pharmaceuticals	<1 mi
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity	Phase 3	Novo Nordisk A/S	<1 mi
Optimal Pacing Rate for Cardiac Resynchronization Therapy	N/A	Medstar Health Research Institute	<1 mi
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products	—	Medtronic	<1 mi
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin	Phase 3	AstraZeneca	<1 mi
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation	Phase 3	Novo Nordisk A/S	<1 mi
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events	Phase 3	Amgen	<1 mi
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy	Phase 4	Dennis M. McNamara, MD, MS	<1 mi
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.	N/A	Medtronic Cardiovascular	<1 mi
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity	Phase 3	Amgen	<1 mi
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE	—	Medtronic Cardiovascular	<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant	Phase 3	Eidos Therapeutics, a BridgeBio company	<1 mi
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)	Phase 3	Intellia Therapeutics	<1 mi
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart	Phase 3	Boehringer Ingelheim	<1 mi
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)	N/A	Biosense Webster, Inc.	<1 mi
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure	N/A	BrioHealth Solutions, Inc.	<1 mi
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease	—	Children's Hospital Medical Center, Cincinnati	<1 mi
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy	Phase 3	Alnylam Pharmaceuticals	<1 mi
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG	Phase 3	Icahn School of Medicine at Mount Sinai	<1 mi
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)	Phase 3	Anthos Therapeutics, Inc.	<1 mi
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention	—	Johns Hopkins University	<1 mi
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS	Phase 3	DalCor Pharmaceuticals	<1 mi
SELUTION 4 De Novo Small Vessel IDE Trial	N/A	M.A. Med Alliance S.A.	<1 mi
The CONFORM Pivotal Trial	N/A	Conformal Medical, Inc	<1 mi
Abatacept in Immune Checkpoint Inhibitor Myocarditis	Phase 3	Massachusetts General Hospital	<1 mi
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR	N/A	Cardiac Dimensions, Inc.	<1 mi
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy	Phase 2	Imbria Pharmaceuticals, Inc.	<1 mi
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)	—	Bristol-Myers Squibb	<1 mi
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation	Phase 3	Johns Hopkins University	<1 mi
Cooperative Assessment of Late Effects for SCD Curative Therapies	—	Vanderbilt University Medical Center	<1 mi
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study	N/A	AtaCor Medical, Inc.	<1 mi
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients	Phase 4	University of Rochester	<1 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	Phase 3	Pierre Fabre Medicament	<1 mi
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients	Phase 3	Colorado Prevention Center	<1 mi
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)	Phase 2	Pfizer	<1 mi
CTSN Embolic Protection Trial	N/A	Icahn School of Medicine at Mount Sinai	<1 mi
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)	Phase 3	Cardiol Therapeutics Inc.	<1 mi
A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM	—	Lexeo Therapeutics	<1 mi
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC	Phase 1	Tenaya Therapeutics	<1 mi
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)	Phase 3	Boehringer Ingelheim	<1 mi
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System	N/A	Boston Scientific Corporation	<1 mi
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)	—	Tenaya Therapeutics	<1 mi
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease	N/A	Population Health Research Institute	<1 mi
BoxX-NoAF Clinical Trial	N/A	AtriCure, Inc.	<1 mi
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections	N/A	Inflammatix	<1 mi
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry	—	Leiden University Medical Center	<1 mi
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis	Phase 2/3	Kiniksa Pharmaceuticals International, plc	<1 mi
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction	Phase 3	Cytokinetics	<1 mi
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure	N/A	Johns Hopkins University	<1 mi
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study	Phase 2/3	Kardigan, Inc.	<1 mi
Quality of Pediatric Resuscitation in a Multicenter Collaborative	—	Children's Hospital of Philadelphia	<1 mi
Cardiopulmonary Bypass Induced Red Blood Cell Lysis	—	University of Maryland, Baltimore	<1 mi
Cord Clamping Among Neonates With Congenital Heart Disease	N/A	Carl Backes, MD	<1 mi
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve	N/A	Edwards Lifesciences	<1 mi
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation	N/A	University of California, San Francisco	<1 mi
The Fourth Left Atrial Appendage Occlusion Study	N/A	Hamilton Health Sciences Corporation	<1 mi
Community Health Worker-Led Intervention to Increase Cardiac Rehabilitation Participation	N/A	Johns Hopkins University	<1 mi
Mobile Health Technology-Enabled AFib Management	N/A	Johns Hopkins University	<1 mi
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial	N/A	Edwards Lifesciences	<1 mi
PRIMARY Ancillary Substudy	N/A	Annetine Gelijns	<1 mi
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment	—	Children's Oncology Group	<1 mi
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure	Phase 3	Boehringer Ingelheim	<1 mi
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure	—	Johns Hopkins University	<1 mi
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma	—	Children's Oncology Group	<1 mi
Transition to KPL-387 Monotherapy Dosing & Administration Study	Phase 2	Kiniksa Pharmaceuticals International, plc	<1 mi
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III	N/A	Endotronix, Inc.	<1 mi
320-detector Computed Tomography to Assess Myocardial Extracellular Volume Fraction in Patients With Atrial Fibrillation Before AF Ablation.	N/A	Johns Hopkins University	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
CORE-COMPARE Pilot Study	N/A	Johns Hopkins University	<1 mi
Brain Volume and Cardiac Function in Heart Failure	N/A	Johns Hopkins University	<1 mi
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction	—	Northwestern University	<1 mi
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)	N/A	University of Michigan	<1 mi
The ENCIRCLE Trial	N/A	Edwards Lifesciences	<1 mi
Focused Orticumab Research for Treating Inflammation in Coronary Arteries	Phase 2	Abcentra	<1 mi
Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism	—	Johns Hopkins University	<1 mi
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy	Phase 3	Lexicon Pharmaceuticals	<1 mi
Rilonacept in Subjects With Cardiac Sarcoidosis	Phase 2	Mayo Clinic	<1 mi
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves	N/A	Edwards Lifesciences	<1 mi
Left Ventricular Structural Predictors of Sudden Cardiac Death	—	Johns Hopkins University	<1 mi
Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk	—	Johns Hopkins University	<1 mi
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)	N/A	Sunnybrook Health Sciences Centre	<1 mi
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women	N/A	Weill Medical College of Cornell University	<1 mi
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]	N/A	Johns Hopkins University	<1 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)	—	Duke University	<1 mi
ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)	Phase 4	University of Maryland St. Joseph Medical Center	8 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	13 mi
Inherited Retinal Degenerative Disease Registry	—	Foundation Fighting Blindness	13 mi
AltaValve Pivotal Trial	N/A	4C Medical Technologies, Inc.	13 mi
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity	Phase 3	SWOG Cancer Research Network	22 mi
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial	Phase 3	Amgen	25 mi
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention	Phase 4	Duke University	26 mi
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias	—	Heart Rhythm Clinical and Research Solutions, LLC	26 mi
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery	Phase 4	University of California, San Francisco	28 mi
Product Surveillance Registry	—	Medtronic	29 mi
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function	Phase 3	AstraZeneca	32 mi
Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies	—	National Cancer Institute (NCI)	32 mi
Technical Development of Cardiovascular Magnetic Resonance Imaging	—	National Heart, Lung, and Blood Institute (NHLBI)	34 mi
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System	—	National Heart, Lung, and Blood Institute (NHLBI)	34 mi
Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study	—	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	34 mi
Evaluating New Radiation Techniques for Cardiovascular Imaging	N/A	National Heart, Lung, and Blood Institute (NHLBI)	34 mi
Nightmare Deconstruction and Reprocessing vs. NightWare Wristband	Phase 2	Uniformed Services University of the Health Sciences	34 mi
New Heart Imaging Techniques to Evaluate Possible Heart Disease	N/A	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	34 mi
Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention	—	National Heart, Lung, and Blood Institute (NHLBI)	34 mi
Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging	—	National Heart, Lung, and Blood Institute (NHLBI)	34 mi
Diabetes and Heart Disease Risk in Blacks	—	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	34 mi
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial	N/A	National Cancer Institute (NCI)	34 mi
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax	—	National Heart, Lung, and Blood Institute (NHLBI)	34 mi
Defining the Brain Phenotype of Children With Williams Syndrome	—	National Institute of Mental Health (NIMH)	34 mi
Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy	—	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	34 mi
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment	—	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	34 mi
Natural History of Noncirrhotic Portal Hypertension	—	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	34 mi
Coronary Microvascular Disease (CMD) Registry	—	Medstar Health Research Institute	36 mi
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery	Phase 3	Yale University	36 mi
STOP AF First Post-Approval Study	—	Medtronic Cardiac Ablation Solutions	36 mi
Simulation Trial of Telemedical Support for Paramedics	N/A	Boston Medical Center	36 mi
Left Atrial Appendage Occlusion Registry (LAAO Registry)	—	American College of Cardiology	36 mi
The JenaValve ALIGN-AR LVAD Registry	N/A	JenaValve Technology, Inc.	36 mi
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II	N/A	Shockwave Medical, Inc.	36 mi
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™	N/A	JenaValve Technology, Inc.	36 mi
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)	Phase 3	NYU Langone Health	36 mi
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia	Phase 3	Novartis Pharmaceuticals	36 mi
STS/ACC TVT Registry Mitral Module	—	American College of Cardiology	36 mi
Prevent Cardiac Surgery Associated AKI Trial	Phase 2	George Washington University	36 mi
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions	N/A	Teleflex	36 mi
Omega-3D: Omega-3 for Diet-Driven Health Disparities	Phase 2	University of Arizona	36 mi
Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry	—	University of Colorado, Denver	36 mi
FORWARD CAD IDE Study	N/A	Shockwave Medical, Inc.	36 mi
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia	Phase 3	Novartis Pharmaceuticals	36 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	—	Columbia University	36 mi
Vosoritide for Short Stature in Turner Syndrome	Phase 2	Roopa Kanakatti Shankar, MBBS, MS	36 mi
Hydrogen's Feasibility and Safety as a Therapy in ECPR	Phase 1	Boston Children's Hospital	36 mi
J-Valve Transfemoral Pivotal Study	N/A	JC Medical, Inc., an affiliate of Edwards Lifesciences LLC	36 mi
A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment	Phase 2	BioMarin Pharmaceutical	36 mi
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).	N/A	Mayra Guerrero	36 mi
Tracking Results of Ablations to Combat AF Registry Generation 2	—	AtriCure, Inc.	36 mi
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block	—	The Hospital for Sick Children	36 mi
Prevail Global Study	N/A	Medtronic Vascular	36 mi
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)	Phase 2/3	Merck Sharp & Dohme LLC	36 mi
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure	N/A	Abbott Medical Devices	36 mi
Implantable Cardioverter Defibrillator (ICD Registry)	—	American College of Cardiology	36 mi
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure	N/A	Boston Scientific Corporation	36 mi
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures	—	Boston Children's Hospital	36 mi
STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)	—	The Society of Thoracic Surgeons	36 mi
Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease	—	Dartmouth-Hitchcock Medical Center	36 mi
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials	—	Vanderbilt University Medical Center	36 mi
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Phase 3	Mezzion Pharma Co. Ltd	36 mi
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR	N/A	Edwards Lifesciences	39 mi
Early Screening and Treatment of Heart Complication in Sickle Cell Disease	Phase 2	Inova Health Care Services	41 mi
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)	Phase 2	Bristol-Myers Squibb	41 mi
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock	—	STAVROS G DRAKOS	41 mi
Left vs Left Randomized Clinical Trial	N/A	Baylor College of Medicine	41 mi
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial	N/A	Inova Health Care Services	41 mi
ELEVATE-HFpEF Clinical Study	N/A	Medtronic Cardiac Rhythm and Heart Failure	41 mi
Medtronic Cardiac Surgery PMCF Registry	—	Medtronic Cardiac Surgery	41 mi
Cardiogenic Shock Working Group Registry	—	Tufts Medical Center	41 mi
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy	Phase 2	Novo Nordisk A/S	41 mi
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs	—	Inova Health Care Services	41 mi
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)	N/A	Medtronic Cardiac Ablation Solutions	41 mi
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova	N/A	Inova Health Care Services	41 mi
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels	—	Inova Health Care Services	41 mi
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation	N/A	Boston Scientific Corporation	41 mi
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis	Phase 2	Novartis Pharmaceuticals	41 mi
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions	N/A	Boston Scientific Corporation	41 mi
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance	—	Minneapolis Heart Institute Foundation	41 mi
In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm	—	Inova Health Care Services	41 mi
Inova Cardiogenic Shock Registry (INOVA SHOCK)	—	Inova Health Care Services	41 mi
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)	N/A	Medtronic Cardiac Ablation Solutions	41 mi
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF	Phase 2	Cytokinetics	44 mi
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension	Phase 2	Retension Pharmaceuticals. Inc.	44 mi
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation	Phase 2	Regeneron Pharmaceuticals	46 mi
Assessment of CCM in HF With Higher Ejection Fraction	N/A	Impulse Dynamics	47 mi
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm	N/A	Kardion Inc	47 mi
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)	N/A	Supira Medical	47 mi
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)	N/A	P+F Products + Features USA Inc.	47 mi
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk	Phase 3	Eli Lilly and Company	47 mi
PARTNER 3 Trial - Aortic Valve-in-Valve	N/A	Edwards Lifesciences	48 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)	Phase 2/3	CSL Behring	48 mi
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions	Phase 4	Yale University	48 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.